• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低危人群肝细胞癌的非侵入性诊断策略。

Non-invasive diagnosis strategy of hepatocellular carcinoma in low-risk population.

机构信息

Department of Gastroenterology and Hepatology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.

Department of Radiology, the First Affiliated Hospital, Sun Yat-Sen University, Yuexiu Distinct, 58 Zhongshan Road 2, Guangzhou, 500018, China.

出版信息

BMC Cancer. 2022 Jun 28;22(1):709. doi: 10.1186/s12885-022-09812-w.

DOI:10.1186/s12885-022-09812-w
PMID:35761201
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9238050/
Abstract

AIMS

With prevalence of hepatocellular carcinoma (HCC) in low-risk population (LRP), establishing a non-invasive diagnostic strategy becomes increasingly urgent to spare unnecessary biopsies in this population. The purposes of this study were to find characterisics of HCC and to establish a proper non-invasive method to diagnose HCC in LRP.

METHODS

A total of 681 patients in LRP (defined as the population without cirrhosis, chronic HBV infection or HCC history) were collected from 2 institutions. The images of computed tomography (CT) and magnetic resonance imaging (MRI) were manually analysed. We divided the patients into the training cohort (n = 324) and the internal validating cohort (n = 139) by admission time in the first institution. The cohort in the second institution was viewed as the external validation (n = 218). A multivariate logistic regression model incorporating both imaging and clinical independent risk predictors was developed. C-statistics was used to evaluate the diagnostic performance.

RESULTS

Besides the major imaging features of HCC (non-rim enhancement, washout and enhancing capsule), tumor necrosis or severe ischemia (TNSI) on imaging and two clinical characteristics (gender and alpha fetoprotein) were also independently associated with HCC diagnosis (all P < 0.01). A clinical model (including 3 major features, TNSI, gender and AFP) was built to diagnose HCC and achieved good diagnostic performance (area under curve values were 0.954 in the training cohort, 0.931 in the internal validation cohort and 0.902 in the external cohort).

CONCLUSIONS

The clinical model in this study developed a satisfied non-invasive diagnostic performance for HCC in LRP.

摘要

目的

由于低危人群(LRP)中肝细胞癌(HCC)的患病率,因此在该人群中建立一种非侵入性诊断策略变得越来越迫切,以免对不必要的活检进行不必要的活检。本研究的目的是找到 HCC 的特征,并建立一种合适的非侵入性方法来诊断 LRP 中的 HCC。

方法

共收集了来自 2 个机构的 681 名 LRP 患者(定义为无肝硬化,慢性乙型肝炎病毒感染或 HCC 病史的人群)。对计算机断层扫描(CT)和磁共振成像(MRI)的图像进行了手动分析。我们根据第一家机构的入院时间将患者分为训练队列(n = 324)和内部验证队列(n = 139)。第二家机构的队列被视为外部验证队列(n = 218)。建立了一个包含影像学和临床独立危险因素的多变量逻辑回归模型。C 统计量用于评估诊断性能。

结果

除了 HCC 的主要影像学特征(非边缘增强,洗脱和增强包膜)外,影像学上的肿瘤坏死或严重缺血(TNSI)和两个临床特征(性别和甲胎蛋白)也与 HCC 诊断独立相关(均 P <0.01)。建立了一个临床模型(包括 3 个主要特征,TNSI,性别和 AFP)来诊断 HCC,并取得了良好的诊断性能(训练队列的曲线下面积值为 0.954,内部验证队列为 0.931,外部队列为 0.902)。

结论

本研究中的临床模型为 LRP 中 HCC 开发了一种令人满意的非侵入性诊断性能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfd0/9238050/131ce47cc5e5/12885_2022_9812_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfd0/9238050/69ef4b622656/12885_2022_9812_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfd0/9238050/2b7d942b9cde/12885_2022_9812_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfd0/9238050/131ce47cc5e5/12885_2022_9812_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfd0/9238050/69ef4b622656/12885_2022_9812_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfd0/9238050/2b7d942b9cde/12885_2022_9812_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfd0/9238050/131ce47cc5e5/12885_2022_9812_Fig3_HTML.jpg

相似文献

1
Non-invasive diagnosis strategy of hepatocellular carcinoma in low-risk population.低危人群肝细胞癌的非侵入性诊断策略。
BMC Cancer. 2022 Jun 28;22(1):709. doi: 10.1186/s12885-022-09812-w.
2
Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.在一项多中心回顾性研究中,1006 个结节的对比超声 LI-RADS LR-5 可识别肝硬化中的肝细胞癌。
J Hepatol. 2018 Mar;68(3):485-492. doi: 10.1016/j.jhep.2017.11.007. Epub 2017 Nov 11.
3
Analysis of Lipiodol uptake in angiography and computed tomography for the diagnosis of malignant versus benign hepatocellular nodules in cirrhotic liver.分析血管造影和计算机断层扫描中碘化油的摄取,以诊断肝硬化肝脏中恶性与良性肝细胞结节。
Eur Radiol. 2019 Dec;29(12):6539-6549. doi: 10.1007/s00330-019-06297-3. Epub 2019 Jun 24.
4
Distinguishing intrahepatic mass-forming biliary carcinomas from hepatocellular carcinoma by computed tomography and magnetic resonance imaging using the Bayesian method: a bi-center study.应用贝叶斯方法通过 CT 和 MRI 鉴别肝内肿块型胆管细胞癌和肝细胞癌:一项双中心研究。
Eur Radiol. 2020 Nov;30(11):5992-6002. doi: 10.1007/s00330-020-06972-w. Epub 2020 Jun 4.
5
Assessment of primary liver carcinomas other than hepatocellular carcinoma (HCC) with LI-RADS v2018: comparison of the LI-RADS target population to patients without LI-RADS-defined HCC risk factors.LI-RADS v2018 对除肝细胞癌(HCC)以外的原发性肝癌的评估:LI-RADS 目标人群与无 LI-RADS 定义的 HCC 风险因素患者的比较。
Eur Radiol. 2020 Feb;30(2):996-1007. doi: 10.1007/s00330-019-06448-6. Epub 2019 Oct 25.
6
LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations.肝脏影像报告和数据系统-超声造影 - 关于高危人群肝细胞癌诊断的超声造影算法提案
Ultraschall Med. 2016 Dec;37(6):627-634. doi: 10.1055/s-0042-112221. Epub 2016 Aug 3.
7
Evaluation of treatment response in hepatocellular carcinoma in the explanted liver with Liver Imaging Reporting and Data System version 2017.采用 2017 版肝脏影像报告和数据系统评估肝移植术后肝癌患者的治疗反应。
Eur Radiol. 2020 Jan;30(1):261-271. doi: 10.1007/s00330-019-06376-5. Epub 2019 Aug 15.
8
Radiomics machine-learning signature for diagnosis of hepatocellular carcinoma in cirrhotic patients with indeterminate liver nodules.基于放射组学机器学习的特征模型在肝硬化患者不确定性质肝脏结节中诊断肝细胞癌的应用。
Eur Radiol. 2020 Jan;30(1):558-570. doi: 10.1007/s00330-019-06347-w. Epub 2019 Aug 23.
9
Predictors and Cumulative Frequency of Hepatocellular Carcinoma in High and Intermediate LI-RADS Lesions: A Cohort Study from a Canadian Academic Institution.高和中 LI-RADS 病变中肝细胞癌的预测因素和累积频率:来自加拿大学术机构的队列研究。
Ann Surg Oncol. 2019 Aug;26(8):2560-2567. doi: 10.1245/s10434-019-07386-9. Epub 2019 Apr 25.
10
Interobserver and intermodality agreement of standardized algorithms for non-invasive diagnosis of hepatocellular carcinoma in high-risk patients: CEUS-LI-RADS versus MRI-LI-RADS.高危人群肝细胞癌无创诊断标准化算法的观察者间和模态间一致性:CEUS-LI-RADS 与 MRI-LI-RADS。
Eur Radiol. 2018 Oct;28(10):4254-4264. doi: 10.1007/s00330-018-5379-1. Epub 2018 Apr 19.

引用本文的文献

1
Enhancing hepatocellular carcinoma diagnosis in non-high-risk patients: a customized ChatGPT model integrating contrast-enhanced ultrasound.提高非高危患者肝细胞癌的诊断水平:一种整合了超声造影的定制ChatGPT模型
Radiol Med. 2025 Apr 15. doi: 10.1007/s11547-025-01994-0.
2
Imaging-Based Prediction of Ki-67 Expression in Hepatocellular Carcinoma: A Retrospective Study.基于影像学的肝细胞癌中Ki-67表达预测:一项回顾性研究
Cancer Med. 2025 Feb;14(4):e70562. doi: 10.1002/cam4.70562.

本文引用的文献

1
Liver cirrhosis.肝硬化。
Lancet. 2021 Oct 9;398(10308):1359-1376. doi: 10.1016/S0140-6736(21)01374-X. Epub 2021 Sep 17.
2
Tumor Necrosis in Hepatocellular Carcinoma-Unfairly Overlooked?肝细胞癌中的肿瘤坏死——被不公平地忽视了?
Ann Surg Oncol. 2021 Feb;28(2):600-601. doi: 10.1245/s10434-020-09402-9. Epub 2020 Nov 22.
3
MRI Ancillary Features for LI-RADS Category 3 and 4 Observations: Improved Categorization to Indicate the Risk of Hepatic Malignancy.MRI 辅助特征用于 LI-RADS 类别 3 和 4 观察:改善分类以指示肝脏恶性肿瘤的风险。
AJR Am J Roentgenol. 2020 Dec;215(6):1354-1362. doi: 10.2214/AJR.20.22802. Epub 2020 Oct 14.
4
How frequently does hepatocellular carcinoma develop in at-risk patients with a negative liver MRI examination with intravenous Gadobenate dimeglumine?在静脉注射钆贝葡胺后行阴性肝脏 MRI 检查的高危患者中,肝细胞癌的发生频率有多高?
Abdom Radiol (NY). 2021 Mar;46(3):969-978. doi: 10.1007/s00261-020-02771-5. Epub 2020 Sep 19.
5
Application of Liver Imaging Reporting and Data System version 2018 ancillary features to upgrade from LR-4 to LR-5 on gadoxetic acid-enhanced MRI.钆塞酸增强 MRI 应用肝脏影像报告和数据系统 2018 年辅助特征升级至 LR-5。
Eur Radiol. 2021 Feb;31(2):855-863. doi: 10.1007/s00330-020-07146-4. Epub 2020 Aug 18.
6
Tumor necrosis as a poor prognostic predictor on postoperative survival of patients with solitary small hepatocellular carcinoma.肿瘤坏死是预测单发小肝癌患者术后生存的不良预后因素。
BMC Cancer. 2020 Jun 29;20(1):607. doi: 10.1186/s12885-020-07097-5.
7
The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis.甲胎蛋白(AFP)诊断肝细胞癌的界值:系统评价和荟萃分析。
PLoS One. 2020 Feb 13;15(2):e0228857. doi: 10.1371/journal.pone.0228857. eCollection 2020.
8
Characteristics, aetiologies and trends of hepatocellular carcinoma in patients without cirrhosis: a United States multicentre study.无肝硬化患者肝细胞癌的特征、病因和趋势:美国多中心研究。
Aliment Pharmacol Ther. 2019 Oct;50(7):809-821. doi: 10.1111/apt.15464. Epub 2019 Sep 1.
9
Expanding the Liver Imaging Reporting and Data System (LI-RADS) v2018 diagnostic population: performance and reliability of LI-RADS for distinguishing hepatocellular carcinoma (HCC) from non-HCC primary liver carcinoma in patients who do not meet strict LI-RADS high-risk criteria.扩大肝脏影像报告和数据系统(LI-RADS) v2018 诊断人群:不符合严格 LI-RADS 高危标准的患者中,LI-RADS 对区分肝细胞癌(HCC)与非 HCC 原发性肝癌的性能和可靠性。
HPB (Oxford). 2019 Dec;21(12):1697-1706. doi: 10.1016/j.hpb.2019.04.007. Epub 2019 Jun 28.
10
LI-RADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance.肝脏影像报告和数据系统(LI-RADS):从其起源到最近纳入美国肝病研究学会(AASLD)临床实践指南的概念与历史回顾
J Hepatocell Carcinoma. 2019 Feb 5;6:49-69. doi: 10.2147/JHC.S186239. eCollection 2019.